Established in 2014, the Thrombosis, Hemostasis, and Cancer Collaborative at the University of Vermont Cancer Center is dedicated to enhancing the lives of cancer patients by reducing vascular complications associated with cancer and its treatments. Thrombosis (blood clots) is the second leading cause of death in cancer patients, significantly increasing the risk of mortality and decreasing quality of life. The Collaborative focuses on minimizing blood clots (thrombosis) and bleeding (hemorrhage) in cancer patients during their treatments.

The Collaborative comprises researchers with decades of expertise in coagulation, cardiovascular disease, and cancer. Its multidisciplinary membership includes oncologists, hematologists, pathologists, neuro-oncologists, gastroenterologists, advanced practice providers, nurses, and pharmacists, along with epidemiology, basic, and translational researchers. The Collaborative also values contributions from patient advocates, nurses, and quality experts.

What makes the University of Vermont Thrombosis, Hemostasis, and Cancer Collaborative unique?

We work TOGETHER!